SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-099283
Filing Date
2022-09-12
Accepted
2022-09-12 17:00:19
Documents
1
Period of Report
2022-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2225655-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2225655-1_4seq1.xml 4 4078
  Complete submission text file 0001104659-22-099283.txt   5751
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Ende Eric J (Reporting) CIK: 0001494386 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 221239129